More recent studies suggested that GNAS mutation might occur in a small subset of gastric adenocarcinomas of the fundic gland type as an alternative mechanism of activating the Wnt/beta-catenin signaling pathway [4]. This evidence concerns the gene GNAS and gastric adenocarcinoma.